Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 15/3/2021
SIETES contiene 93212 citas

 1 a 20 de 363 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Nguyen D-D, Marchese M, Cone EB, Paciotti M, Basaria S, Bhojani N, Trinh Q-D. Investigation of suicidality and psychological adverse events in patients treated with finasteride. JAMA Dermatol 2020:11 de noviembre. [Ref.ID 103784]
2. Cita con resumen
Lafaurie M, Olivier P, Khouri C, Atzenhoffer M, Bihan K, Durrieu G, Montastruc J-L. Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey. Eur J Clin Pharmacol 2020;76:603-4. [Ref.ID 103616]
3. Cita con resumen
Sánchez Caballero D. Varios colectivos proponen una ley para regularizar el cannabis medicinal y legalizar el autocultivo y consumo. 2019:11 de diciembre. [Ref.ID 103219]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW. Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016. JAMA Intern Med 2018;178:julio. [Ref.ID 102882]
5. Cita con resumen
Anónimo. UK grants sildenafil over-the-counter status. DIA Daily 2017:2. [Ref.ID 102150]
6. Cita con resumen
Alshehri GH, Keers RN, Ashcroft DM. Frequency and nature of medication errors and adverse drug events in mental health hospitals: a systematic review. Drug Saf 2017;40:871-86. [Ref.ID 102076]
7. Cita con resumen
Gedeborg R, Svennblad B, Holm L, Sjögren H, Bardage C, Personne M, Sjöberg G, Feltelius N, Zethelius B. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf 2017;26:518-27. [Ref.ID 101958]
8. Cita con resumen
Aznar-Lou I, Fernández A, Gil-Gibau M, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-María MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol MA, Jové AM, Rubio-Valera M. Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol 2017;83:1328-40. [Ref.ID 101944]
9. Cita con resumen
Anónimo. FDA approves Differin Gel 0.1% for over-the-counter use to treat acne. U.S. Food and Drug Administration 2016:8 de julio. [Ref.ID 100485]
10. Cita con resumen
McCarthy M. Novartis agrees to pay $390m in US kickback case. BMJ 2015;351:h5784. [Ref.ID 99637]
11.Enlace a cita original Cita con resumen
Anónimo. Oral diclofenac: prescription-only in United Kingdom. United Kingdom . WHO Drug Information 2015;29:14. [Ref.ID 98951]
12.Enlace a cita original Cita con resumen
Anónimo. Oral diclofenac no longer available without prescription. Drug Safety Update 2015;8:4. [Ref.ID 98834]
13. Cita con resumen
Anónimo. Oral diclofenac no longer available OTC. Drug Ther Bull 2015;53:14-7. [Ref.ID 98777]
14. Cita con resumen
Guinovart MC, Figueras A, Llop JC, Llor C. Obtaining antibiotics without prescription in Spain in 2014: even easier now than 6 years ago. . J Antimicrob Chemother 2015;70:1270-1. [Ref.ID 98714]
15. Cita con resumen
Anónimo. Bloomberg: pharma use of matchbacks for digital marketing raises concerns. DIA Daily 2014:10 de diciembre. [Ref.ID 98385]
16. Cita con resumen
Elia J. Government drops appeal to limit access to morning-after pill. Journal Watch 2013:12 de junio. [Ref.ID 96592]
17. Cita con resumen
Anónimo. OTC emergency contraceptive to hit store shelves by August 1. DIA Daily 2013:24 de junio. [Ref.ID 95637]
18. Cita con resumen
Shear MD. Judge refuses to drop his order allowing morning-after pill for all ages. N Y Times (Print) 2013:10 de mayo. [Ref.ID 95387]
19. Cita con resumen
Anónimo. Judge says plan B ID requirement would impede access for low-income buyers. DIA Daily 2013:8 de mayo. [Ref.ID 95362]
20. Cita con resumen
Anónimo. FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older . U.S. Food and Drug Administration 2013:30 de abril. [Ref.ID 95334]
Seleccionar todas
 1 a 20 de 363 siguiente >>